Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
7
Neutral
4
Bullish
3
Bearish
16
Neutral
4
Bullish
26
Bearish
9
Neutral
0
Bullish
23
Discovery themes featuring this stock
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Sagility Limited is a technology-enabled healthcare solutions and services provider, offering operations support to both payers and providers in the healthcare sector.
The company reported robust financial performance in Q3 FY26, with a revenue of ₹19,712 million, marking a 35.7% year-on-year growth, driven by strong client acquisition and existing client expansion.
Sagility's strategic acquisition of BroadPath Healthcare Solutions in 2025 significantly increased its exposure to seasonal open enrollment work, indicating strategic growth in healthcare-focused services.
With the acquisition of BirchAI in March 2024, Sagility aims to integrate advanced GenAI technology, reinforcing its competitive edge in healthcare service automation and enhancing operational efficiency.
Sagility's commitment to sustainability and corporate responsibility is recognized by earning the EcoVadis Committed Badge, indicating strong ESG performance in its operations.
IT - Services
IT Enabled Services
20,682 Cr
Moderate Risk
24.3
30.6
0.9
2.3
57.90
35.82
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stock| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1682.30 | 29,097 Cr | 43.86 | 12.98 | 0.00 | 27.21 | 27.85 | 18.39 | ||
581.35 | 25,610 Cr | 46.85 | 6.53 | 1.85 | 15.63 | 17.57 | 6.10 | ||
4422.35 | 25,181 Cr | 122.35 | 34.81 | 0.00 | 28.46 | 28.75 | 9.13 | ||
1418.55 | 21,213 Cr | 48.39 | 6.51 | 0.00 | 12.88 | 15.72 | 11.20 | ||
42.95 | 20,682 Cr | 24.34 | 2.32 | 0.00 | 8.98 | 11.63 | 7.37 | ||
527.00 | 13,285 Cr | 62.30 | 10.95 | 0.13 | 30.03 | 20.16 | 6.02 | ||
805.70 | 10,049 Cr | 23.48 | 1.77 | 1.77 | 8.48 | 13.05 | 5.56 | ||
| Median: 7 Co. | — | 805.70 | 21,213 Cr | 46.85 | 6.53 | 0.00 | 15.63 | 17.57 | 7.37 |
Upcoming Result Date: May 11, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Sagility Ltd (SAGILITY) is currently trading at 44.18 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sagility Limited is a technology-enabled healthcare solutions and services provider, offering operations support to both payers and providers in the healthcare sector. The company reported robust financial performance in Q3 FY26, with a revenue of ₹19,712 million, marking a 35.7% year-on-year growth, driven by strong client acquisition and existing client expansion. Sagility's strategic acquisition of BroadPath Healthcare Solutions in 2025 significantly increased its exposure to seasonal open enrollment work, indicating strategic growth in healthcare-focused services. With the acquisition of BirchAI in March 2024, Sagility aims to integrate advanced GenAI technology, reinforcing its competitive edge in healthcare service automation and enhancing operational efficiency. Sagility's commitment to sustainability and corporate responsibility is recognized by earning the EcoVadis Committed Badge, indicating strong ESG performance in its operations.
Over the past 52 weeks, Sagility Ltd has traded between a low of ₹35.82 and a high of ₹57.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sagility Ltd has a market capitalization of approximately 20,682.11. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sagility Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.34 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 20,682.11 Cr, Sagility Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sagility Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sagility Ltd is 24.34. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Elara has set a target price of ₹54, implying about 26% upside from the April 17, 2026 closing price of ₹43 on the NSE.
Sagility India is a technology-enabled business process management (BPM) company that provides services like claims processing and revenue cycle management exclusively for the US healthcare industry.
Sagility's stock surged over 9% after the global brokerage firm Nomura initiated coverage with a 'Buy' rating and a price target suggesting a 47.4% potential upside.
The stock jumped after brokerage firm Nomura initiated coverage with a 'Buy' rating and a Rs 55 price target, suggesting a significant upside potential of 47.4%.
Earnings Webinar
Sagility Limited will hold an investors/analyst webinar on May 12, 2026 at 7:30 PM IST to discuss audited financial results for the quarter and year ended March 31, 2026; CEO and CFO to attend.
Board Meeting Intimation
Board meeting on May 12, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026; may recommend final dividend and approve an employee share‑based incentive scheme; trading window closed until May 14, 2026.
Board Meeting
Sagility Limited scheduled a Board meeting on May 12, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a potential final dividend and employee share‑based incentive scheme.
